{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:45:47Z","timestamp":1768736747688,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.meegid.2021.104706","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T20:10:58Z","timestamp":1610223058000},"page":"104706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The association of the heterogeneity of HBV reverse transcriptase quasispecies with antiviral efficacy after treatment with nucleos(t)ide analogues for 10\u00a0years"],"prefix":"10.1016","volume":"89","author":[{"given":"Tai-Cheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Hua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Hang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-Qin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.meegid.2021.104706_bb0005","first-page":"S351","article-title":"Engineering immune therapy against hepatitis B virus","volume":"37","author":"Akbar","year":"2007","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.meegid.2021.104706_bb0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2015.03.022","article-title":"Viral quasispecies","volume":"479\u2013480","author":"Andino","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.meegid.2021.104706_bb0015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2008.12.018","article-title":"Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy","volume":"50","author":"Chen","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2021.104706_bb0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cmi.2015.10.007","article-title":"Increased intrahepatic quasispecies heterogeneity correlates with off-treatment sustained response to nucleos(t)ide analogues in e antigen-positive chronic hepatitis B patients","volume":"22","author":"Chen","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.meegid.2021.104706_bb0025","series-title":"Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level","author":"Chen","year":"2019"},{"key":"10.1016\/j.meegid.2021.104706_bb0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2012.09.017","article-title":"Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapy","volume":"58","author":"Cheng","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2021.104706_bb0035","series-title":"Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe","first-page":"251","volume":"18","author":"Colagrossi","year":"2018"},{"key":"10.1016\/j.meegid.2021.104706_bb0040","first-page":"51","article-title":"Viruses as quasispecies: biological implications","volume":"299","author":"Domingo","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.meegid.2021.104706_bb0045","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1053\/gast.2001.22454","article-title":"Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection","volume":"120","author":"Doo","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2021.104706_bb0050","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1128\/JCM.01723-13","article-title":"Comparison of next-generation sequencing and clone-based sequencing in analysis of hepatitis B virus reverse transcriptase quasispecies heterogeneity","volume":"51","author":"Gong","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2021.104706_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.03.021","article-title":"Prediction of virological response by pretreatment hepatitis B virus reverse transcriptase quasispecies heterogeneity: the advantage of using next-generation sequencing","volume":"21","author":"Han","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.meegid.2021.104706_bb0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.meegid.2021.104706_bb0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3350\/cmh.2017.0005","article-title":"Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: real-life experience","volume":"23","author":"Kim","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.meegid.2021.104706_bb0070","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4254\/wjh.v7.i8.1030","article-title":"Current and future antiviral drug therapies of hepatitis B chronic infection","volume":"7","author":"Koumbi","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.meegid.2021.104706_bb0075","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.meegid.2021.104706_bb0080","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","article-title":"Clustal W and Clustal X version 2.0","volume":"23","author":"Larkin","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.meegid.2021.104706_bb0085","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/molbev\/msx149","article-title":"SMS: smart model selection in PhyML","volume":"34","author":"Lefort","year":"2017","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.meegid.2021.104706_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2017.88","article-title":"A comparative study on the characterization of hepatitis B virus quasispecies by clone-based sequencing and third-generation sequencing","volume":"6","author":"Li","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.meegid.2021.104706_bb0095","first-page":"5528","article-title":"Early changes in quasispecies variant after antiviral therapy for chronic hepatitis B","volume":"17","author":"Liang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.meegid.2021.104706_bb0100","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/gut.2010.226225","article-title":"Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy","volume":"60","author":"Liu","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.meegid.2021.104706_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2019.02.012","article-title":"Prevalence of the entecavir-resistance-inducing mutation rtA186T in a large cohort of Chinese hepatitis B virus patients","volume":"164","author":"Liu","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2021.104706_bb0110","first-page":"1943","article-title":"Pathways to extinction: beyond the error threshold","volume":"365","author":"Manrubia","year":"2010","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.meegid.2021.104706_bb0115","doi-asserted-by":"crossref","first-page":"10307","DOI":"10.1128\/JVI.00996-06","article-title":"Molecular evolution of hepatitis B virus over 25 years","volume":"80","author":"Osiowy","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2021.104706_bb0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jvh.12013","article-title":"Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs","volume":"20","author":"Peveling-Oberhag","year":"2013","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.meegid.2021.104706_bb0125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/135965350901400504","article-title":"Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients","volume":"14","author":"Pollicino","year":"2009","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.meegid.2021.104706_bb0130","first-page":"214","article-title":"Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces","volume":"7","author":"Ramezani","year":"2015","journal-title":"Iran J. Microbiol."},{"key":"10.1016\/j.meegid.2021.104706_bb0135","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.3748\/wjg.v20.i18.5435","article-title":"Hepatitis B virus genetic mutations and evolution in liver diseases","volume":"20","author":"Shen","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.meegid.2021.104706_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-981-13-9151-4_6","article-title":"Present and future therapies for chronic hepatitis B","volume":"1179","author":"Tao","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.meegid.2021.104706_bb0145","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1128\/JVI.02164-09","article-title":"Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases","volume":"84","author":"Wang","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2021.104706_bb0150","first-page":"474","article-title":"Genotypes and evolution characteristics of three patients with poor response to initial treatment of Lamivudine and Adefovir dipivoxil for hepatitis","volume":"26","author":"Wang","year":"2012","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1016\/j.meegid.2021.104706_bb0155","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1440-1746.2009.05924.x","article-title":"Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease","volume":"24","author":"Wong","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.meegid.2021.104706_bb0160","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/molbev\/msm088","article-title":"PAML 4: phylogenetic analysis by maximum likelihood","volume":"24","author":"Yang","year":"2007","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.meegid.2021.104706_bb0165","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/molbev\/msi097","article-title":"Bayes empirical bayes inference of amino acid sites under positive selection","volume":"22","author":"Yang","year":"2005","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.meegid.2021.104706_bb0170","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s00535-017-1334-1","article-title":"Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma","volume":"52","author":"Zhang","year":"2017","journal-title":"J. Gastroenterol."},{"issue":"Suppl. 1","key":"10.1016\/j.meegid.2021.104706_bb0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1478-3231.2010.02399.x","article-title":"Hepatitis B virus resistance to antiviral drugs: where are we going?","volume":"31","author":"Zoulim","year":"2011","journal-title":"Liver Int."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:44:59Z","timestamp":1761576299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134821000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":35,"alternative-id":["S1567134821000034"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104706","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of the heterogeneity of HBV reverse transcriptase quasispecies with antiviral efficacy after treatment with nucleos(t)ide analogues for 10\u00a0years","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104706"}}